IPO 2021

Genetic Analysis AS performed an Initial Public Offering (IPO) and became listed on the Spotlight Stock Market on October 1st, 2021. Below is a list of documents from the IPO with important information for an investment in GA and videos presenting both the company and representatives from the management.

The subscription period was closed on 13.09.2021. Read more about the outcome here.

SUBSCRIPTION PERIOD 08-22. NOVEMBER 2023 FOR WARRANT TO 2

Please find form for subscribing to the warrant TO 2 below:

Anmälan om utnyttjande av teckningsoptioner av serie TO 2 – GEAN TO 2 – ISIN NO0011054231Download

Please make sure that you have read the subscription information published by the company on 03.11.2023 thoroughly before considering an execution.

SUBSCRIPTION PERIOD 02-16. NOVEMBER 2022 FOR WARRANT TO 1

Please find forms for subscribing to the warrant TO 1 in your preferred language:

Anmälan om utnyttjande av teckningsoptioner av serie TO 1 – GEAN TO 1 – ISIN NO0011054223Download
Varsel om utøvelse av tegningsretter TO 1 – GEAN TO 1- ISIN NO0011054223Download

Please make sure you have read the subscription information published by the company on 02.11.2022 thoroughly before considering an execution.


IPO DOCUMENTS

Genetic Analysis AS – Teaser – EnglishDownload
Genetic Analysis AS – Teaser – SwedishDownload
Genetic Analysis AS – Investment Prospectus Download
Genetic Analysis AS – Investment Prospectus with Norwegian summaryDownload
Genetic Analysis AS – TilläggsdokumentDownload

Read more details about the listing process from GA’s Financial Adviser Sedermera Fondkommission here.


VIDEOS

See the Web-TV presentation of GA by CEO Ronny Hermansen and CCO Anita Patel Jusnes held 26.08.2021 on Aktieportföljen Live:

Watch the Genetic Analysis’ video to quickly learn what the GA-map technology is all about!